Additionally, Hauschner-H et al. observed that platelets from Calreticulin-mutated ET patients were less reactive to ADP (adenosine diphosphate) stimulation than control or JAK2-mutated platelets [111]. The gene discussed is JAK2; the disease is essential thrombocythemia.